Loading…

Remedicalizing cannabis : science, industry, and drug policy /

"When cannabis tincture was withdrawn as a medical product in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these me...

Full description

Bibliographic Details
Call Number:Libro Electrónico
Main Author: Taylor, Suzanne (Research fellow) (Author)
Format: Electronic eBook
Language:Inglés
Published: Montreal ; Kingston ; London ; Chicago : McGill-Queen's University Press, [2022]
Series:Intoxicating histories ; 3.
Subjects:
Online Access:Texto completo
Table of Contents:
  • Understanding Cannabis: Pharmacology, Laboratory Research, and Drug Control, 1964-82
  • Cannabis in the Clinic: Clinical Pharmacology and the Therapeutic Applications of Cannabis, 1973-82
  • Evidence-Based Policy? The Development of Expert Committees, 1972-82
  • Industrializing Cannabis: The Pharmaceutical Industry and the Remedicalization of Cannabis, 1973-2001
  • Forces of Necessity: Lay Advocacy and the Remedicalization of Cannabis, 1973-2001
  • Establishing Therapeutic Cannabis: The Role of Expert Advice, 1997-2001
  • From Anecdotal to Evidence-Based Medicine: The Role of Clinical Trials, 1995-2005
  • Accessing Cannabis-Based Medicinal Products (CBMPS), 2009-21.